Product image of Vizimpro (Dacomitinib) supplied by GNH India

Vizimpro

Active Ingredient:
Dacomitinib
Origin:
EU

Vizimpro (Dacomitinib)

Vizimpro (dacomitinib) is an oral prescription medication used to treat non-small cell lung cancer. This targeted therapy helps slow disease progression in adults with specific genetic mutations. It belongs to the EGFR inhibitor class and is taken once daily. Vizimpro is available by prescription only.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Vizimpro is prescribed for adults with non-small cell lung cancer (NSCLC) that has spread to nearby tissues or other parts of the body. It is used when cancer cells have certain genetic changes, such as EGFR mutations. This medication helps control tumor growth by blocking signals that promote cancer cell division. It is typically prescribed after other treatments have been tried.

Side Effects

  • Vizimpro works by targeting specific proteins in cancer cells to slow their growth. Patients may experience side effects like diarrhea, skin rash, or dry skin as the body adjusts. These effects vary in intensity and are typically managed with supportive care. Regular monitoring helps track how the medication is working.

Precautions & Warnings

  • Vizimpro should be taken exactly as prescribed by a healthcare provider. Patients should report any severe or persistent side effects, such as breathing difficulties or severe diarrhea, immediately. It is important to attend all follow-up appointments to monitor progress. Avoid grapefruit products unless approved by a doctor.

Avoid Interactions

  • Vizimpro may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Patients should inform their doctor about all prescription and over-the-counter drugs they are taking. Alcohol and certain supplements may also interact, so it is best to discuss these with a healthcare provider. Always check with a doctor before starting new medications.

Frequently Asked Questions

Vizimpro is used to treat non-small cell lung cancer in adults with specific genetic mutations.

Vizimpro is an oral medication taken once daily, as prescribed by a doctor.

Common side effects include diarrhea, skin rash, and dry skin.

Always consult a healthcare provider before combining Vizimpro with other drugs to avoid interactions.

No, Vizimpro requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dacomitinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT